The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
PVA Embolization Particles-Global Market Insights and Sales Trends 2024
Synopsis
Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.
The global PVA Embolization Particles market size is expected to reach US$ 1186.9 million by 2029, growing at a CAGR of 5.3% from 2023 to 2029. The market is mainly driven by the significant applications of PVA Embolization Particles in various end use industries. The expanding demands from the Uterine Fibroid Embolization, Prostatic Artery Embolization, Liver Tumor Embolization and Trauma Embolization, are propelling PVA Embolization Particles market. Conventional/Irregular PVA, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Compressible and Spherical PVA segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for PVA Embolization Particles market, driven by demand from China, the second largest economy with some signs of stabilising, the PVA Embolization Particles market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for PVA Embolization Particles, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global PVA Embolization Particles market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global PVA Embolization Particles market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, PVA Embolization Particles sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of PVA Embolization Particles covered in this report include Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical, INterface BIOmaterials and Alicon, etc.
The global PVA Embolization Particles market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials
Alicon
Global PVA Embolization Particles market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global PVA Embolization Particles market, Segment by Type:
Conventional/Irregular PVA
Compressible and Spherical PVA
Global PVA Embolization Particles market, by Application
Uterine Fibroid Embolization
Prostatic Artery Embolization
Liver Tumor Embolization
Trauma Embolization
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of PVA Embolization Particles manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of PVA Embolization Particles in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.
The global PVA Embolization Particles market size is expected to reach US$ 1186.9 million by 2029, growing at a CAGR of 5.3% from 2023 to 2029. The market is mainly driven by the significant applications of PVA Embolization Particles in various end use industries. The expanding demands from the Uterine Fibroid Embolization, Prostatic Artery Embolization, Liver Tumor Embolization and Trauma Embolization, are propelling PVA Embolization Particles market. Conventional/Irregular PVA, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Compressible and Spherical PVA segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for PVA Embolization Particles market, driven by demand from China, the second largest economy with some signs of stabilising, the PVA Embolization Particles market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for PVA Embolization Particles, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global PVA Embolization Particles market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global PVA Embolization Particles market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, PVA Embolization Particles sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of PVA Embolization Particles covered in this report include Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical, INterface BIOmaterials and Alicon, etc.
The global PVA Embolization Particles market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials
Alicon
Global PVA Embolization Particles market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global PVA Embolization Particles market, Segment by Type:
Conventional/Irregular PVA
Compressible and Spherical PVA
Global PVA Embolization Particles market, by Application
Uterine Fibroid Embolization
Prostatic Artery Embolization
Liver Tumor Embolization
Trauma Embolization
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of PVA Embolization Particles manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of PVA Embolization Particles in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 PVA Embolization Particles Market Overview
1.1 PVA Embolization Particles Product Overview
1.2 PVA Embolization Particles Market Segment by Type
1.2.1 Conventional/Irregular PVA
1.2.2 Compressible and Spherical PVA
1.3 Global PVA Embolization Particles Market Size by Type
1.3.1 Global PVA Embolization Particles Market Size Overview by Type (2018-2029)
1.3.2 Global PVA Embolization Particles Historic Market Size Review by Type (2018-2023)
1.3.3 Global PVA Embolization Particles Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America PVA Embolization Particles Sales Breakdown by Type (2018-2023)
1.4.2 Europe PVA Embolization Particles Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific PVA Embolization Particles Sales Breakdown by Type (2018-2023)
1.4.4 Latin America PVA Embolization Particles Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa PVA Embolization Particles Sales Breakdown by Type (2018-2023)
2 Global PVA Embolization Particles Market Competition by Company
2.1 Global Top Players by PVA Embolization Particles Sales (2018-2023)
2.2 Global Top Players by PVA Embolization Particles Revenue (2018-2023)
2.3 Global Top Players by PVA Embolization Particles Price (2018-2023)
2.4 Global Top Manufacturers PVA Embolization Particles Manufacturing Base Distribution, Sales Area, Product Type
2.5 PVA Embolization Particles Market Competitive Situation and Trends
2.5.1 PVA Embolization Particles Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by PVA Embolization Particles Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PVA Embolization Particles as of 2022)
2.7 Date of Key Manufacturers Enter into PVA Embolization Particles Market
2.8 Key Manufacturers PVA Embolization Particles Product Offered
2.9 Mergers & Acquisitions, Expansion
3 PVA Embolization Particles Status and Outlook by Region
3.1 Global PVA Embolization Particles Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global PVA Embolization Particles Historic Market Size by Region
3.2.1 Global PVA Embolization Particles Sales in Volume by Region (2018-2023)
3.2.2 Global PVA Embolization Particles Sales in Value by Region (2018-2023)
3.2.3 Global PVA Embolization Particles Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global PVA Embolization Particles Forecasted Market Size by Region
3.3.1 Global PVA Embolization Particles Sales in Volume by Region (2024-2029)
3.3.2 Global PVA Embolization Particles Sales in Value by Region (2024-2029)
3.3.3 Global PVA Embolization Particles Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global PVA Embolization Particles by Application
4.1 PVA Embolization Particles Market Segment by Application
4.1.1 Uterine Fibroid Embolization
4.1.2 Prostatic Artery Embolization
4.1.3 Liver Tumor Embolization
4.1.4 Trauma Embolization
4.1.5 Other
4.2 Global PVA Embolization Particles Market Size by Application
4.2.1 Global PVA Embolization Particles Market Size Overview by Application (2018-2029)
4.2.2 Global PVA Embolization Particles Historic Market Size Review by Application (2018-2023)
4.2.3 Global PVA Embolization Particles Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America PVA Embolization Particles Sales Breakdown by Application (2018-2023)
4.3.2 Europe PVA Embolization Particles Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific PVA Embolization Particles Sales Breakdown by Application (2018-2023)
4.3.4 Latin America PVA Embolization Particles Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa PVA Embolization Particles Sales Breakdown by Application (2018-2023)
5 North America PVA Embolization Particles by Country
5.1 North America PVA Embolization Particles Historic Market Size by Country
5.1.1 North America PVA Embolization Particles Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America PVA Embolization Particles Sales in Volume by Country (2018-2023)
5.1.3 North America PVA Embolization Particles Sales in Value by Country (2018-2023)
5.2 North America PVA Embolization Particles Forecasted Market Size by Country
5.2.1 North America PVA Embolization Particles Sales in Volume by Country (2024-2029)
5.2.2 North America PVA Embolization Particles Sales in Value by Country (2024-2029)
6 Europe PVA Embolization Particles by Country
6.1 Europe PVA Embolization Particles Historic Market Size by Country
6.1.1 Europe PVA Embolization Particles Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe PVA Embolization Particles Sales in Volume by Country (2018-2023)
6.1.3 Europe PVA Embolization Particles Sales in Value by Country (2018-2023)
6.2 Europe PVA Embolization Particles Forecasted Market Size by Country
6.2.1 Europe PVA Embolization Particles Sales in Volume by Country (2024-2029)
6.2.2 Europe PVA Embolization Particles Sales in Value by Country (2024-2029)
7 Asia-Pacific PVA Embolization Particles by Region
7.1 Asia-Pacific PVA Embolization Particles Historic Market Size by Region
7.1.1 Asia-Pacific PVA Embolization Particles Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific PVA Embolization Particles Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific PVA Embolization Particles Sales in Value by Region (2018-2023)
7.2 Asia-Pacific PVA Embolization Particles Forecasted Market Size by Region
7.2.1 Asia-Pacific PVA Embolization Particles Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific PVA Embolization Particles Sales in Value by Region (2024-2029)
8 Latin America PVA Embolization Particles by Country
8.1 Latin America PVA Embolization Particles Historic Market Size by Country
8.1.1 Latin America PVA Embolization Particles Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America PVA Embolization Particles Sales in Volume by Country (2018-2023)
8.1.3 Latin America PVA Embolization Particles Sales in Value by Country (2018-2023)
8.2 Latin America PVA Embolization Particles Forecasted Market Size by Country
8.2.1 Latin America PVA Embolization Particles Sales in Volume by Country (2024-2029)
8.2.2 Latin America PVA Embolization Particles Sales in Value by Country (2024-2029)
9 Middle East and Africa PVA Embolization Particles by Country
9.1 Middle East and Africa PVA Embolization Particles Historic Market Size by Country
9.1.1 Middle East and Africa PVA Embolization Particles Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa PVA Embolization Particles Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa PVA Embolization Particles Sales in Value by Country (2018-2023)
9.2 Middle East and Africa PVA Embolization Particles Forecasted Market Size by Country
9.2.1 Middle East and Africa PVA Embolization Particles Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa PVA Embolization Particles Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sirtex Medical
10.1.1 Sirtex Medical Company Information
10.1.2 Sirtex Medical Introduction and Business Overview
10.1.3 Sirtex Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sirtex Medical PVA Embolization Particles Products Offered
10.1.5 Sirtex Medical Recent Development
10.2 Merit Medical
10.2.1 Merit Medical Company Information
10.2.2 Merit Medical Introduction and Business Overview
10.2.3 Merit Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merit Medical PVA Embolization Particles Products Offered
10.2.5 Merit Medical Recent Development
10.3 Cook Medical
10.3.1 Cook Medical Company Information
10.3.2 Cook Medical Introduction and Business Overview
10.3.3 Cook Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Cook Medical PVA Embolization Particles Products Offered
10.3.5 Cook Medical Recent Development
10.4 BTG Medical
10.4.1 BTG Medical Company Information
10.4.2 BTG Medical Introduction and Business Overview
10.4.3 BTG Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2018-2023)
10.4.4 BTG Medical PVA Embolization Particles Products Offered
10.4.5 BTG Medical Recent Development
10.5 Boston Scientific Corporation
10.5.1 Boston Scientific Corporation Company Information
10.5.2 Boston Scientific Corporation Introduction and Business Overview
10.5.3 Boston Scientific Corporation PVA Embolization Particles Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Boston Scientific Corporation PVA Embolization Particles Products Offered
10.5.5 Boston Scientific Corporation Recent Development
10.6 Terumo Corporation
10.6.1 Terumo Corporation Company Information
10.6.2 Terumo Corporation Introduction and Business Overview
10.6.3 Terumo Corporation PVA Embolization Particles Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Terumo Corporation PVA Embolization Particles Products Offered
10.6.5 Terumo Corporation Recent Development
10.7 HENGRUI Medical
10.7.1 HENGRUI Medical Company Information
10.7.2 HENGRUI Medical Introduction and Business Overview
10.7.3 HENGRUI Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2018-2023)
10.7.4 HENGRUI Medical PVA Embolization Particles Products Offered
10.7.5 HENGRUI Medical Recent Development
10.8 INterface BIOmaterials
10.8.1 INterface BIOmaterials Company Information
10.8.2 INterface BIOmaterials Introduction and Business Overview
10.8.3 INterface BIOmaterials PVA Embolization Particles Sales, Revenue and Gross Margin (2018-2023)
10.8.4 INterface BIOmaterials PVA Embolization Particles Products Offered
10.8.5 INterface BIOmaterials Recent Development
10.9 Alicon
10.9.1 Alicon Company Information
10.9.2 Alicon Introduction and Business Overview
10.9.3 Alicon PVA Embolization Particles Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Alicon PVA Embolization Particles Products Offered
10.9.5 Alicon Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 PVA Embolization Particles Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 PVA Embolization Particles Industrial Chain Analysis
11.4 PVA Embolization Particles Market Dynamics
11.4.1 PVA Embolization Particles Industry Trends
11.4.2 PVA Embolization Particles Market Drivers
11.4.3 PVA Embolization Particles Market Challenges
11.4.4 PVA Embolization Particles Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 PVA Embolization Particles Distributors
12.3 PVA Embolization Particles Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
